Research location
Toulouse
Cedex 9, France
Advertisement
Research activity in Toulouse
Cedex 9, FranceCureCurrent currently publishes aggregate city-level research activity for this location: 12 trials and 12 site observations.
The map is centered on registry-derived city coordinates. Circle size reflects published trial activity.
Below are current trials with one or more ClinicalTrials.gov site observations in this city. Results are paginated 50 per page, with recruiting studies shown first.
Trials with sites in Toulouse
12 linked trials · page 1 of 1Study of IDE397 in Participants With Solid Tumors Harboring MTAP DeletionNCT04794699 · 2021-04-14 · 1 site observation
ACTIVE_NOT_RECRUITING
Evaluation of the Safety and Efficacy of TLD in Patients with COPDNCT03639051 · 2019-05-23 · 1 site observation
ACTIVE_NOT_RECRUITING
A Study Comparing LY900014 to Insulin Lispro (Humalog) in Adults With Type 1 Diabetes Using Insulin Pump TherapyNCT03830281 · 2019-02-14 · 1 site observation
COMPLETED
Study of Pembrolizumab (MK-3475) in Adults With Recurrent/Metastatic Cutaneous Squamous Cell Carcinoma (cSCC) or Locally Advanced Unresectable cSCC (MK-3475-629/KEYNOTE-629)NCT03284424 · 2017-10-26 · 1 site observation
COMPLETED
A Study of Pimavanserin for the Treatment of Agitation and Aggression in Subjects With Alzheimer's DiseaseNCT03118947 · 2017-02-23 · 1 site observation
COMPLETED
Study to Examine the Safety and Efficacy of Pimavanserin for the Treatment of Agitation and Aggression in Alzheimer's Disease (SERENE)NCT02992132 · 2016-11-01 · 1 site observation
TERMINATED
An Efficacy and Safety Study of Lanabecestat (LY3314814) in Early Alzheimer's DiseaseNCT02245737 · 2014-09-30 · 1 site observation
TERMINATED
3-arm Trial to Evaluate Pasireotide LAR/Everolimus Alone/in Combination in Patients With Lung/Thymus NET - LUNA TrialNCT01563354 · 2013-08-16 · 1 site observation
COMPLETED
Study to Allow Access to Pasireotide for Patients Benefiting From Pasireotide Treatment in Novartis-sponsored StudiesNCT01794793 · 2013-06-10 · 1 site observation
COMPLETED
Study to Evaluate the Safety, Tolerability and the Effect of BMS-241027 on Cerebrospinal Fluid Biomarkers in Subjects With Mild Alzheimer's DiseaseNCT01492374 · 2012-02-01 · 1 site observation
COMPLETED
A Multicenter, Double Blind, Placebo-Controlled, Safety and Tolerability Study of BMS-708163 in Patients With Prodromal Alzheimer's DiseaseNCT00890890 · 2009-05-01 · 1 site observation
TERMINATED
A Study of Erlotinib (Tarceva) After Surgery With or Without Adjuvant Chemotherapy in Non-Small Cell Lung Carcinoma (NSCLC) Patients Who Have Epidermal Growth Factor Receptor (EGFR) Positive TumorsNCT00373425 · 2006-09-01 · 1 site observation
COMPLETED
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.